Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - OPERATING INCOME
Operating Income URGN - UroGen Pharma Ltd.
-65.5 M
LAST VALUE
15.73%
2 YEAR CAGR
3.22%
5 YEAR CAGR
-34.47%
10 YEAR CAGR